Task: Answer the multiple choice question.
Query: Which drug exhibits a 11.333\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a: O=C(Cn1nc(C(=O)O)c2ccccc2c1=O)Nc1ccc(Br)cc1
b: O=C(Cn1c(NCCO)nc2ccccc21)NCCc1ccccc1
c: COc1cc(NC(=O)CSc2ccc(-c3ccco3)nn2)cc(OC)c1
Answer: c. COc1cc(NC(=O)CSc2ccc(-c3ccco3)nn2)cc(OC)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1cc(NC(=O)CSc2ccc(-c3ccco3)nn2)cc(OC)c1
COc1cc(NC(=O)CSc2ccc(-c3ccco3)nn2)cc(OC)c1
N-(3,5-dimethoxyphenyl)-2-[6-(furan-2-yl)pyridazin-3-yl]sulfanylacetamide